Kurasikirwa uremu Semaglutide CAS 910463-68-2
Tsanangudzo
Semaglutide(910463-68-2) mushonga unorwisa chirwere cheshuga unotengeswa pasi pemazita emhando seOzempic, Wegovy, uye Rybelsus.Inoshandiswa kurapa chirwere cheshuga chechipiri uye kugadzirisa uremu husingaperi.Mushonga unoshanda zvakafanana neyemunhu glucagon-sepeptide-1 (GLP-1) nekuwedzera insulin secretion, iyo inotungamira kune yakagadziridzwa shuga metabolism.Inogoverwa se metered subcutaneous jekiseni mune prefilled peni, kana semumuromo fomu.Imwe yemabhenefiti ayo pamusoro pemamwe mishonga yeantidiabetic ndeyekuti ine nguva yakareba yekuita, saka, kamwe chete-a-vhiki jekiseni yakakwana.
Uses
Semaglutide inoshandiswa kugadzirisa chirwere cheshuga 2 pamwe chete nekuchinja kwehupenyu, zvakadai sezvirambidzo zvekudya uye kuwedzera kwekuita muviri.Inoshandawo nekuderedza kufamba kwechikafu kuburikidza nemudumbu uye inogona kuderedza chido uye kukonzera kuora muviri.Pakave pasina mishumo yakabudiswa yehepatotoxicity inonzi semaglutide therapy.
Nzira yekuita
Semaglutide inonzi glucagon-like peptide-1 receptor agonist.Inowedzera kugadzirwa kwe insulini, hormone inoderedza shuga yeropa.Inotaridzawo kuwedzera kukura kwemasero e-β mupancreas, ari nzvimbo dzekugadzirwa kwe insulin.Inodzivisawo glucagon, iyo hormone inowedzera shuga yeropa.Inowedzerawo kuderedza kudya kwekudya nekuderedza kudya uye kunonoka kudya mudumbu.Nenzira iyi inoderedza mafuta emuviri.
Biological Activity
Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217), glucagon-like peptide 1 (GLP-1) analogue, iGLP-1 receptor agonist ine mukana wekurapa kwerudzi rwechipiri chirwere cheshuga mellitus. (T2DM).